IMI PROTECT (Work Package 2): Calcium Channel Blockers and Cancer
NCT01587742
·
clinicaltrials.gov ↗
COMPLETED
Status
1
Enrollment
INDUSTRY
Sponsor class
Conditions
Hypertension
Interventions
DRUG:
CCB use
Sponsor
GlaxoSmithKline